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Introduction {#jah31557-sec-0004}
============

Cardio‐metabolic diseases are the epidemics of our time, and they inflict individual suffering on a global scale. Just 2 diseases alone---cardiovascular diseases (CVD) and diabetes---are responsible for 19 million deaths each year, with more than 80% of these disorders occurring in low‐ and middle‐income countries.[1](#jah31557-bib-0001){ref-type="ref"} As the largest democratic, middle‐income country in the world, Brazil has, over the past several decades, undergone one of the world\'s most rapid demographic and economic transitions. More than 85% of Brazilians currently live in urban areas,[2](#jah31557-bib-0002){ref-type="ref"} and have acquired the risks of chronic diseases typical of an urbanized culture. Also, population aging has resulted in an increased cardio‐metabolic disease burden, currently with a rapid lifestyle transition characterized by a significant decrease in physical activity and increase in overweight and obesity.

A survey conducted in Brazil reported around 87% of the population not engaging in leisure time physical activity (LTPA), which is much higher than the prevalence in the United States.[3](#jah31557-bib-0003){ref-type="ref"}, [4](#jah31557-bib-0004){ref-type="ref"} According to the National Health Survey, the prevalence of practice of the recommended level of LTPA was 22.5%.[5](#jah31557-bib-0005){ref-type="ref"} Because cardio‐metabolic diseases are more prevalent among the poor, their rising burden threatens to widen the already large gap in health care between the poor and affluent. It has been estimated that the identification of risk factors and subsequent reduction explain ≈44% to 76% of the decline in mortality from CVD alone in high‐income countries.[6](#jah31557-bib-0006){ref-type="ref"} Evidence from high‐income settings suggests that it is possible to use lifestyle interventions to curb the epidemic of chronic diseases and promote cardio‐metabolic health in other settings. For example, Brazil, as a large middle‐income country, has shown a significant decrease in noncommunicable diseases mortality, related to successful smoking and hypertension control policies.[7](#jah31557-bib-0007){ref-type="ref"} However, the rising prevalence of obesity and physical inactivity may threaten the achievements already made.

To ensure the health benefits of the population and the cost‐effectiveness of preventive interventions, the current focus of cardio‐metabolic health care should be expanded to include essential lifestyle interventions. Despite the fact that the Brazilian government has already implemented an integrated policy plan to address the problem of physical inactivity, few resources are available to comprehensively evaluate the impact of the high and ever‐increasing prevalence of physical inactivity on the burden of cardio‐metabolic diseases. Although increasing attention has been given to the promotion of healthy lifestyles,[8](#jah31557-bib-0008){ref-type="ref"}, [9](#jah31557-bib-0009){ref-type="ref"} more well‐designed prevention studies in Brazilian populations are still needed.

Therefore, we conducted a comprehensive assessment of the evidence about the effects of LTPA on cardio‐metabolic parameters in the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil), the first multicenter cohort study of Brazilians focusing on cardio‐metabolic diseases. The aims of our study were (1) to comprehensively evaluate the association of LTPA with intermediate cardio‐metabolic biomarkers, and (2) to investigate the benefits of LTPA relating to cardio‐metabolic outcomes, including the risk of hypertension and diabetes and the predicted 10‐year risk of CVD.

Methods {#jah31557-sec-0005}
=======

Study Population {#jah31557-sec-0006}
----------------

The design and methodology of the ELSA‐Brasil have been detailed elsewhere.[10](#jah31557-bib-0010){ref-type="ref"}, [11](#jah31557-bib-0011){ref-type="ref"} Briefly, 15 105 civil servants (6887 men and 8218 women) aged 35 to 74 years were enrolled at 6 sites from August 2008 to December 2010 for baseline data collection. Of the 15 105 participants enrolled, ≈52% of the participants were white, 16% black, 28% mixed, 2% Asian, and 1% indigenous. The large sample size and wide variety of well‐characterized variables of the ELSA‐Brasil make it a unique resource for comprehensive and systematic investigations of the determinants and distribution of cardio‐metabolic diseases in Brazilian adults. Furthermore, the availability of data on CVD intermediaries and cardio‐metabolic diseases allows for the comprehensive assessment of the biological mechanisms by which physical inactivity may affect CVD risk. Participants with self‐reported coronary heart disease, CVDs, or peripheral artery disease at baseline were excluded. Participants without information on total physical activity were additionally excluded from the 11 547 participants free of coronary heart disease, CVD, and peripheral artery disease, and the current study consists of 10 585 participants in total. The ELSA‐Brasil was approved by the Institutional Review Boards (IRB) in Hospital Universitário da Universidade de São Paulo IRB (Universidade de São Paulo), Fundação Oswaldo Cruz IRB (Fundação Oswaldo Cruz), Instituto de Saúde Coletiva da Universidade Federal da Bahia IRB (Universidade Federal da Bahia), Universidade Federal de Minas Gerais IRB (Universidade Federal de Minas Gerais), Centro de Ciências da Saúde da Universidade Federal do Espírito Santo IRB (Universidade Federal do Espírito Santo), and Hospital de Clínicas de Porto Alegre IRB (Universidade Federal do Rio Grande do Sul). All individuals who participated in the study provided written informed consent.

Measurement of Physical Activity {#jah31557-sec-0007}
--------------------------------

Questionnaires and interviews were used to collect the information, with an emphasis on the social and racial inequalities and health‐related living conditions that are distinctive in Brazil. In particular, the International Physical Activity Questionnaire (IPAQ) was used to ascertain various types of activities in the domains of LTPA and transport. The detailed protocol of the IPAQ can be found elsewhere.[12](#jah31557-bib-0012){ref-type="ref"} In brief, IPAQ is an instrument designed primarily for adult physical activity surveillance. Frequency and duration for walking, moderate‐intensity activities, and vigorous‐intensity activities were collected for each type of activity using the IPAQ.

Measurement of Cardio‐Metabolic Outcomes {#jah31557-sec-0008}
----------------------------------------

Medical assessments and measurements of clinical and subclinical parameters were conducted at baseline visit.[13](#jah31557-bib-0013){ref-type="ref"} The body mass index (BMI) was weight in kilograms divided by height in meters, squared. Blood pressure (BP) was taken using a validated oscillometric device (Omron HEM 705CPINT) after a 5‐minute rest with the subject in a sitting position in a quiet, temperature‐controlled room (20--24°C). Three measurements were taken at 1‐minute intervals. The mean of the 2 latest BP measurements was calculated and used for our analyses. Conventional 12‐lead ECGs were performed using a digital device (Atria 6100; Burdick, Cardiac Science Corporation, Bothell, WA, USA) and were analyzed according to the Minnesota Code.[14](#jah31557-bib-0014){ref-type="ref"} The Framingham Risk Score was calculated for the participants of the ELSA‐Brasil, and the detailed scoring scheme has been reported elsewhere.[16](#jah31557-bib-0015){ref-type="ref"} Based on the recent American College of Cardiology/American Heart Association (ACC/AHA) Guideline on the Assessment of Cardiovascular Risk, an arteriosclerotic cardiovascular disease (ASCVD) Risk Score was also computed.[17](#jah31557-bib-0016){ref-type="ref"}

Diabetes status used in the current study was classified by using laboratory measurements. A 12‐hour fasting blood sample was drawn by venipuncture soon after each participant arrived at the baseline clinic visit. A 2‐hour 75‐g oral glucose tolerance test was then administered to participants without known diabetes. Glucose was measured centrally by the hexokinase method (ADVIA Chemistry; Siemens, Deerfield, IL). Percent glycosylated hemoglobin (HbA1c) was measured using high‐pressure liquid chromatography (Bio‐Rad Laboratories, Hercules, CA). Participants were classified as having diabetes if they reached the threshold for fasting plasma glucose (7.0 mmol/L), 2‐hour postload plasma glucose (11.1 mmol/L), or HbA1c (6.5%).[15](#jah31557-bib-0018){ref-type="ref"}, [18](#jah31557-bib-0017){ref-type="ref"} A participant was classified to have hypertension if systolic blood pressure (SBP) was ≥140 mm Hg, diastolic blood pressure (DBP) was ≥90 mm Hg, or she/he had taken any medication to treat hypertension in the past 2 weeks. According to Framingham Risk Score, participants were classified as with low, intermediate, or high 10‐year risk of CVD if they have 6% or less, 6% to 20%, or 20% or more CVD risk in 10 years.[16](#jah31557-bib-0015){ref-type="ref"} According to the ACC/AHA ASCVD Risk Score, participants were classified as with low, intermediate, or high 10‐year risk of ASCVD if they have 5% or less, 5% to 7.5%, or 7.5% or more ASCVD risk in 10 years.[17](#jah31557-bib-0016){ref-type="ref"}

Statistical Analysis {#jah31557-sec-0009}
--------------------

Based on current recommendations from the American College of Sports Medicine and the AHA, participants who had at least 150 minutes of moderate activities per week or at least 75 minutes of vigorous activities per week during their leisure time were categorized as active.[19](#jah31557-bib-0019){ref-type="ref"} Participants who did not meet the recommendations were considered inactive. Baseline characteristics and LTPA‐related traits are summarized below for the active and the inactive women and men. The χ^2^ test and the *t* test were used to evaluate the difference between the active and the inactive participants.

The cardio‐metabolic outcomes for the sex‐specific analyses include SBP, DBP, heart rate, the Framingham Risk Score for CVD, the ACC/AHA ASCVD Risk Score, hypertension, diabetes, and the predicted 10‐year risk of CVD. To ensure the robustness of our results, different sets of covariates were considered for adjustment: (1) age (continuous), race, and research centers; (2) covariates in (1), along with BMI; and (3) covariates in (2), along with smoking and alcohol consumption. Generalized linear regression was used for continuous outcome variables, and regular logistic and ordered logistic regression models were used for categorical variables with the inactive category treated as the reference. The coefficients or ORs with 95% CIs were computed from the generalized linear regression models or logistic regression models, respectively.

To evaluate the robustness of primary findings, we also conducted 3 sets of sensitivity analyses using (1) the additional adjustment for education and income, (2) the alternative definition of being active versus inactive (≥1000 kcal/week versus \<1000 kcal/week following criteria recommended by the Centers for Disease Control and Prevention, the American College of Sports Medicine, and the US Surgeon General[20](#jah31557-bib-0020){ref-type="ref"}, [21](#jah31557-bib-0021){ref-type="ref"}), and (3) mixed‐effect models with the effects of study centers treated as random effects. Standard metabolic equivalents were assigned to different activity categories, and we converted them into the total LTPA‐related energy expenditure in kilocalories per week by multiplying metabolic equivalents by the frequency and the duration of each activity category and body weight.[22](#jah31557-bib-0022){ref-type="ref"}, [23](#jah31557-bib-0023){ref-type="ref"} Generalized linear mixed models and cumulative link mixed models were used for categorical outcomes, and linear mixed models were used for continuous outcomes.

To explore the potential mediation, a preliminary mediation analysis was conducted to quantify the direct effects of LTPA on the risk of hypertension, diabetes, and CVD, along with the mediated effects through SBP, DBP, heart rate, the Framingham Risk Score, and the ACC/AHA ASCVD Risk Score.[24](#jah31557-bib-0024){ref-type="ref"}, [25](#jah31557-bib-0025){ref-type="ref"} The proportions of effects mediated were also computed for each mediator--outcome combination.

Statistical analyses were conducted using R statistical package, version 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria). Two‐sided inference with *P*\<0.05 was considered statistically significant.

Results {#jah31557-sec-0010}
=======

Study Population {#jah31557-sec-0011}
----------------

In total, there were 5752 (54%) women and 4833 (46%) men. The mean age was 51.64 (SD=8.71) years for women and 51.54 (SD=9.02) for men. Among women, 51% identified themselves as white, 18% as black, 27% as mixed, 4% as Asian and indigenous; among men, 52% identified themselves as white, 14% as black, 30% as mixed, 3% as Asian and indigenous. Around 12% of the women and 14% of the men were current smokers, and 25% of the women and 34% of the men were former smokers. Current drinkers and former drinkers constitute 65% and 20% of the women and 77% and 19% of the men, respectively. Other baseline characteristics are also summarized in Table [1](#jah31557-tbl-0001){ref-type="table-wrap"}. All demographic characteristics and LTPA‐related traits significantly differ between the active men and the inactive men (all *P*\<0.05). The active women and the inactive women are significantly different in terms of all characteristics except for age (*P*=0.92 for continuous age variable and 0.64 for age strata).

###### 

Baseline Characteristics of Leisure Time Physically Inactive Versus Active (AHA Recommendations)[a](#jah31557-note-0001){ref-type="fn"} Women (N=5752) and Men (N=4833) of the ELSA‐Brasil

                                         Women   Men                                                                                                       
  -------------------------------------- ------- -------- ------- ------- -------- -------- ---------- ------- -------- ------- -------- -------- -------- ----------
  Demographic characteristics                                                                                                                              
  Age, y                                 51.64   8.71     51.64   8.65    51.62    8.97     0.92       51.54   9.02     52.12   8.95     50.10    9.06     \<0.0001
  Race                                                                                      \<0.0001                                                       0.008
  White                                  2945    51       2220    49      725      61                  2496    52       1737    50       759      55       
  Mixed                                  1534    27       1276    28      258      22                  1459    30       1050    30       409      29       
  Black                                  1007    18       870     19      137      12                  658     14       495     14       163      12       
  Other                                  204     4        152     3       52       4                   156     3        121     4        35       3        
  Age strata                                                                                0.64                                                           \<0.0001
  35 to 44                               1296    23       1020    22      276      23                  1150    24       733     21       417      30       
  45 to 54                               2319    40       1861    41      458      39                  1972    41       1393    40       579      42       
  55 to 64                               1638    28       1292    28      346      29                  1250    26       984     29       266      19       
  65 to 74                               499     9        396     9       103      9                   461     10       336     10       125      9        
  Smoking                                                                                   \<0.0001                                                       \<0.0001
  Current smokers                        697     12       606     13      91       8                   665     14       543     16       122      9        
  Former smokers                         1415    25       1104    24      311      26                  1643    34       1216    35       427      31       
  Never smokers                          3640    63       2859    63      781      66                  2524    52       1686    49       838      60       
  Alcohol consumption                                                                       \<0.0001                                                       \<0.0001
  Current drinkers                       3738    65       2855    62      883      75                  3718    77       2572    75       1146     83       
  Former drinkers                        1126    20       959     21      167      14                  895     19       706     20       189      14       
  Never drinkers                         878     15       747     16      131      11                  218     5        166     5        52       4        
  Education                                                                                 \<0.0001                                                       \<0.0001
  Without college degree                 2554    44       2255    49      299      25                  2319    48       1822    53       497      36       
  With college degree                    3198    56       2314    51      884      75                  2514    52       1624    47       890      64       
  Per capita family income, US dollars   1825    1501     1681    1406    2378     1712     \<0.0001   1670    1354     1556    1287     1953     1469     \<0.0001
  PA‐related traits                                                                                                                                        
  Total days/wk of PA                    2.09    2.82     1.17    1.94    5.65     2.83     \<0.0001   2.63    3.01     1.44    2.07     5.58     2.94     \<0.0001
  Walking, min/wk                        57.16   96.30    49.36   91.85   87.31    106.65   \<0.0001   71.67   115.26   63.60   107.32   91.72    130.87   \<0.0001
  Light PA, min/wk                       17.93   60.78    6.63    25.47   66.29    117.69   \<0.0001   19.43   63.62    7.10    24.55    55.59    111.38   \<0.0001
  Vigorous PA, min/wk                    38.91   101.59   1.14    7.79    184.78   152.20   \<0.0001   62.04   126.04   3.24    12.79    208.13   158.17   \<0.0001
  Total MET‐h/wk                         9.50    16.51    3.31    5.87    33.42    21.72    \<0.0001   13.45   19.59    4.40    6.77     35.93    22.69    \<0.0001

AHA indicates American Heart Association; ELSA‐Brazil, Brazilian Longitudinal Study of Adult Health; MET, metabolic equivalents; PA, physical activity.

American Heart Association guidelines recommend at least 150 min/wk moderate exercise or 75 min/wk vigorous exercise.

Association Between Physical Activity Status and Cardio‐Metabolic Outcomes {#jah31557-sec-0012}
--------------------------------------------------------------------------

Physical activity status was directly associated with each measure for cardio‐metabolic health at baseline among both women and men who participated in the ELSA‐Brasil (all *P*\<0.05) (Table [2](#jah31557-tbl-0002){ref-type="table-wrap"}). The active participants, compared to the inactive, tended to have lower BMI, SBP and DBP, heart rate, and Framingham Risk Score for CVD. Also, the prevalence of hypertension and diabetes, along with the predicted 10‐year risk of CVD, appeared to be lower among the active participants (Table [2](#jah31557-tbl-0002){ref-type="table-wrap"}).

###### 

Comparison of Cardio‐Metabolic Measures at Baseline Between Leisure Time Physically Inactive Versus Active Women (N=5752) and Men (N=4833) (AHA Recommendations)[a](#jah31557-note-0002){ref-type="fn"}

  Cardio‐Metabolic Variables   Women      Men                                                                                                       
  ---------------------------- ---------- ------- -------- ------- -------- ------- ---------- ---------- ------- -------- ------- -------- ------- ----------
  BMI, kg/m^2^                 26.79      4.89    27.13    4.96    25.48    4.36    \<0.0001   26.79      4.14    26.99    4.32    26.28    3.58    \<0.0001
  SBP, mm Hg                   117.14     16.48   117.81   16.78   114.55   14.97   \<0.0001   125.15     16.24   125.94   16.85   123.18   14.42   \<0.0001
  DBP, mm Hg                   73.87      10.11   74.30    10.26   72.18    9.31    \<0.0001   78.87      10.64   79.56    10.85   77.15    9.88    \<0.0001
  Heart rate, bpm              71.00      9.70    71.38    9.73    69.55    9.44    \<0.0001   69.15      10.51   70.45    10.33   65.93    10.26   \<0.0001
  FHS CVD score                6.43       6.07    6.69     6.24    5.46     5.26    \<0.0001   13.49      8.90    14.43    9.01    11.16    8.16    \<0.0001
  ASCVD score                  0.03       0.05    0.03     0.05    0.03     0.04    \<0.0001   0.08       0.09    0.09     0.09    0.07     0.08    \<0.0001
  Hypertension                                                                      \<0.0001                                                        \<0.0001
  No                           4026       70      3115     68      911      77                 3071       64      2085     61      986      71      
  Yes                          1722       30      1450     32      272      23                 1757       36      1358     39      399      29      
  Diabetes (ADA)                                                                    \<0.0001                                                        \<0.0001
  No                           4888       85      3837     84      1051     89                 3787       78      2605     76      1182     85      
  Yes                          863        15      731      16      132      11                 1044       22      839      24      205      15      
  FHS 10‐yr risk of CVD        \<0.0001                                                        \<0.0001                                             
  \<6                          3676       64      2841     62      835      71                 1177       24      701      20      476      34      
  ≤6 and \<20                  1781       31      1468     32      313      26                 2483       51      1792     52      691      50      
  ≥20                          290        5       255      6       35       3                  1161       24      942      27      219      16      
  10‐yr risk of ASCVD          0.001                                                           \<0.0001                                             
  \<5                          4691       82      3682     81      1009     85                 2318       48      1482     43      836      60      
  ≤5 and \<7.5                 418        7       350      8       68       6                  657        14      490      14      167      12      
  ≥7.5                         638        11      532      12      106      9                  1846       38      1463     42      383      28      

ADA indicates American Diabetes Association; ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; FHS, Framingham Heart Study; SBP, systolic blood pressure.

American Heart Association guidelines recommend at least 150 min/wk moderate exercise or 75 min/wk vigorous exercise.

After taking into account age, race, study sites, BMI, smoking status, and alcohol consumption (Model 3), the sex‐specific relation between physical activity status and the measures of cardio‐metabolic health at baseline remained evident. Specifically, the average SBP of the active women was 1.33 (95% CI: −2.30 to −0.37, *P*=0.01) mm Hg lower than the inactive women; the average SBP of the active men was 1.08 (95% CI: −2.05 to −0.11, *P*=0.03) mm Hg lower than the inactive men (Table [3](#jah31557-tbl-0003){ref-type="table-wrap"}). The average DBP was 0.79 (95% CI: −1.41 to −0.17, *P*=0.01) mm Hg lower among the active women and 1.71 (95% CI: −2.35 to −1.07, *P*\<0.0001) mm Hg lower among the active men, compared with their inactive counterparts. The active women had an average heart rate 1.96 (95% CI: −2.59 to −1.33, *P*\<0.0001) bpm slower than that of the inactive women; the average heart rate of the active men was 4.32 (95% CI: −4.98 to −3.66, *P*\<0.0001) bpm slower. Framingham Risk Scores for CVD were favorable among the active (women: β=−0.37, 95% CI: −0.66 to −0.08, *P*=0.01; men: β=−0.83, 95% CI: −1.16 to −0.50, *P*\<0.0001). The estimated ORs comparing the active versus the inactive women were 0.78 (95% CI: 0.66--0.92, *P*=0.003) for hypertension and 0.78 for the predicted 10‐year risk of CVD (95% CI: 0.65--0.93, *P*=0.005). Among men, the estimated ORs comparing the active versus the inactive were 0.75 (95% CI: 0.65--0.87, *P*=0.0002) for hypertension and 0.73 (95% CI: 0.61--0.87, *P*=0.0006) for diabetes. The predicted 10‐year risk of CVD based on Framingham Risk Scores was significantly lower among the active men with a 33% reduction in risk (OR=0.67 comparing the high‐risk category versus the low‐risk category, 95% CI: 0.57--0.78, *P*\<0.0001). The predicted 10‐year risk of ASCVD based on the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk was significantly lower among the active men with a 29% reduction in risk (OR=0.71 comparing the high‐risk category versus the low‐risk category, 95% CI: 0.59--0.85, *P*\<0.0003).

###### 

Associations of Cardio‐Metabolic Measures With LTPA Status (AHA Recommendations)[a](#jah31557-note-0003){ref-type="fn"} at Baseline Among Women (N=1183 Active and 4569 Inactive) and Men (N=1387 Active and 3446 Inactive) in the ELSA‐Brasil

  Cardio‐Metabolic Variables                        Model 1[b](#jah31557-note-0004){ref-type="fn"}   Model 2          Model 3                                                                 
  ------------------------------------------------- ------------------------------------------------ ---------------- ---------- ------- ---------------- ---------- ------- ---------------- ----------
  Women                                                                                                                                                                                       
  SBP, mm Hg                                        −2.24                                            −3.21 to −1.28   \<0.0001   −1.36   −2.32 to −0.41   0.01       −1.33   −2.30 to −0.37   0.01
  DBP, mm Hg                                        −1.67                                            −2.31 to −1.04   \<0.0001   −0.77   −1.38 to −0.16   0.01       −0.79   −1.41 to −0.17   0.01
  Heart rate, bpm                                   −2.09                                            −2.71 to −1.47   \<0.0001   −2.03   −2.65 to −1.40   \<0.0001   −1.96   −2.59 to −1.33   \<0.0001
  FHS CVD score                                     −0.99                                            −1.30 to −0.69   \<0.0001   −0.67   −0.97 to −0.37   \<0.0001   −0.37   −0.66 to −0.08   0.01
  ASCVD score                                       −0.53                                            −0.75 to −0.30   \<0.0001   −0.41   −0.64 to −0.18   0.0004     −0.16   −0.38 to 0.06    0.14
  Hypertension                                      0.67                                             0.57 to 0.78     \<0.0001   0.77    0.65 to 0.91     0.002      0.78    0.66 to 0.92     0.003
  Diabetes[d](#jah31557-note-0006){ref-type="fn"}   0.69                                             0.56 to 0.84     0.0003     0.81    0.65 to 0.99     0.04       0.83    0.67 to 1.03     0.09
  FHS 10‐yr risk of CVD                             0.60                                             0.50 to 0.70     \<0.0001   0.68    0.57 to 0.81     \<0.0001   0.78    0.65 to 0.93     0.005
  10‐yr risk of ASCVD                               0.57                                             0.46 to 0.72     \<0.0001   0.64    0.51 to 0.81     0.0002     0.78    0.61 to 1.01     0.06
  Men                                                                                                                                                                                         
  SBP, mm Hg                                        −1.49                                            −2.47 to −0.52   0.003      −1.02   −1.98 to −0.06   0.04       −1.08   −2.05 to −0.11   0.03
  DBP, mm Hg                                        −2.23                                            −2.89 to −1.57   \<0.0001   −1.72   −2.35 to −1.09   \<0.0001   −1.71   −2.35 to −1.07   \<0.0001
  Heart rate, bpm                                   −4.63                                            −5.29 to −3.98   \<0.0001   −4.47   −5.13 to −3.82   \<0.0001   −4.32   −4.98 to −3.66   \<0.0001
  FHS CVD score                                     −1.75                                            −2.12 to −1.37   \<0.0001   −1.47   −1.84 to −1.10   \<0.0001   −0.83   −1.16 to −0.50   \<0.0001
  ASCVD score                                       −0.85                                            −1.22 to −0.48   \<0.0001   −0.68   −1.05 to −0.32   0.0003     −0.25   −0.60 to 0.10    0.16
  Hypertension                                      0.69                                             0.60 to 0.80     \<0.0001   0.76    0.66 to 0.88     0.0003     0.75    0.65 to 0.87     0.0002
  Diabetes                                          0.62                                             0.52 to 0.74     \<0.0001   0.68    0.57 to 0.82     \<0.0001   0.73    0.61 to 0.87     0.0006
  FHS 10‐yr risk of CVD                             0.52                                             0.45 to 0.60     \<0.0001   0.56    0.48 to 0.65     \<0.0001   0.67    0.57 to 0.78     \<0.0001
  10‐yr risk of ASCVD                               0.52                                             0.44 to 0.62     \<0.0001   0.57    0.48 to 0.67     \<0.0001   0.71    0.59 to 0.85     0.0003

AHA indicates American Heart Association; ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; ELSA‐Brazil, Brazilian Longitudinal Study of Adult Health; FHS, Framingham Heart Study; LTPA, leisure time physical activity; SBP, systolic blood pressure.

AHA guidelines recommend at least 150 min/wk moderate exercise or 75 min/wk vigorous exercise.

Estimates and 95% CIs were from regular logistic regression or ordered logistic regression or generalized linear regression models. Model 1 was adjusted for age, race, and study centers; Model 2 was adjusted for age, race, study centers, and BMI; Model 3 was adjusted for age, race, study centers, BMI, smoking status, and alcohol consumption.

Mean differences (βs) estimated from the generalized linear regression models were reported for continuous outcomes; ORs estimated from the logistic regression models are reported for discrete outcomes. For CVD risk scores, ORs comparing the high‐risk category vs the low‐risk category were obtained from ordered logistic regression models.

Diabetes was defined using self‐reported information and laboratory measurements (fasting plasma glucose level ≥7.0 mmol/L, 2‐hour postload plasma glucose ≥11.1 mmol/L, or HbA1c ≥6.5%).

Sensitivity Analysis {#jah31557-sec-0013}
--------------------

To evaluate the robustness of primary findings, we also conducted 3 sets of sensitivity analyses using (1) the additional adjustment for education and income, (2) the alternative definition of being active versus inactive (≥1000 kcal/week versus \<1000 kcal/week following criteria recommended by the Centers for Disease Control and Prevention, the American College of Sports Medicine, and the US Surgeon General[20](#jah31557-bib-0020){ref-type="ref"}, [21](#jah31557-bib-0021){ref-type="ref"}), and (3) mixed‐effect models with the effects of study centers treated as random effects. The associations discovered in the primary analysis did not change appreciably when we further adjusted for the socioeconomic variables (Table [4](#jah31557-tbl-0004){ref-type="table-wrap"}). Similar to the results from the primary analysis with the adjustment for the final set of covariates, the energy expenditure from LTPA ≥1000 kcal/week was associated with improved cardio‐metabolic health (Table [5](#jah31557-tbl-0005){ref-type="table-wrap"}). The findings from the sensitivity analyses for the risk of hypertension, diabetes, and the predicted 10‐year risk of CVD were consistent with those from the primary analysis, although the significance of the associations for intermediaries was attenuated. Results from the sensitivity analysis based on mixed‐effect models were almost identical to those from the primary analysis based on fixed‐effect models (Table [6](#jah31557-tbl-0006){ref-type="table-wrap"}).

###### 

Robustness of the Sex‐Specific Associations Between LTPA Status[a](#jah31557-note-0007){ref-type="fn"} and Cardio‐Metabolic Measures With Respect to Education and Income[b](#jah31557-note-0008){ref-type="fn"}

  Cardio‐Metabolic Variables                        Women (N=1183 Active and 4569 Inactive)   Men (N=1387 Active and 3446 Inactive)                                       
  ------------------------------------------------- ----------------------------------------- --------------------------------------- ---------- ------- ---------------- ----------
  SBP, mm Hg                                        −0.72                                     −1.69 to 0.25                           0.15       −0.41   −1.37 to 0.56    0.41
  DBP, mm Hg                                        −0.53                                     −1.15 to 0.09                           0.10       −1.35   −2.00 to −0.71   \<0.0001
  Heart rate, bpm                                   −2.08                                     −2.22 to −1.44                          \<0.0001   −4.25   −4.91 to −3.58   \<0.0001
  FHS CVD score                                     −0.20                                     −0.50 to 0.10                           0.19       −0.68   −1.01 to −0.35   \<0.0001
  ASCVD score                                       −0.11                                     −0.34 to 0.11                           0.32       −0.19   −0.54 to 0.16    0.29
  Hypertension                                      0.83                                      0.70 to 0.98                            0.03       0.79    0.68 to 0.92     0.002
  Diabetes[d](#jah31557-note-0010){ref-type="fn"}   0.89                                      0.72 to 1.11                            0.31       0.77    0.64 to 0.93     0.005
  FHS 10‐yr risk of CVD                             0.84                                      0.70 to 1.00                            0.06       0.71    0.61 to 0.83     \<0.0001
  10‐yr risk of ASCVD                               0.87                                      0.67 to 1.12                            0.27       0.77    0.64 to 0.93     0.007

AHA indicates American Heart Association; ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; FHS, Framingham Heart Study; LTPA, leisure time physical activity; SBP, systolic blood pressure.

AHA guidelines recommend at least 150 min/wk moderate exercise or 75 min/wk vigorous exercise.

Estimates and 95% CIs were from regular logistic regression or ordered logistic regression or generalized linear regression models adjusting for age, race, study centers, BMI, smoking status, alcohol consumption, education, and income.

ORs are reported to discrete outcomes, and mean differences (βs) were reported for continuous outcomes. For CVD risk scores, ORs comparing the high‐risk category vs the low‐risk category were obtained from ordered logistic regression models.

Diabetes was defined using self‐reported information and laboratory measurements (fasting plasma glucose level ≥7.0 mmol/L, 2‐hour postload plasma glucose ≥11.1 mmol/L, or HbA1c ≥6.5%).

###### 

Robustness of the Sex‐Specific Associations Between LTPA Status[a](#jah31557-note-0011){ref-type="fn"} and Cardio‐Metabolic Measures With Respect to an Alternative Definition of Physical Inactivity (LTPA‐Related EE ≥1000 kcal/wk)[b](#jah31557-note-0012){ref-type="fn"}

  Cardio‐Metabolic Variables                        Women (N=1183 Active and 4569 Inactive)   Men (N=1387 Active and 3446 Inactive)                                       
  ------------------------------------------------- ----------------------------------------- --------------------------------------- ---------- ------- ---------------- ----------
  SBP, mm Hg                                        −0.70                                     −1.61 to 0.22                           0.14       −0.70   −1.59 to 0.19    0.12
  DBP, mm Hg                                        −0.50                                     −1.08 to 0.09                           0.10       −1.54   −2.13 to −0.95   \<0.0001
  Heart rate, bpm                                   −1.54                                     −2.13 to −0.94                          \<0.0001   −3.67   −4.28 to −3.06   \<0.0001
  FHS CVD score                                     −0.17                                     −0.45 to 0.11                           0.23       −0.53   −0.83 to −0.23   0.001
  ASCVD score                                       −0.04                                     −0.25 to 0.17                           0.71       −0.27   −0.59 to 0.05    0.10
  Hypertension                                      0.85                                      0.73 to 0.99                            0.03       0.85    0.74 to 0.97     0.01
  Diabetes[d](#jah31557-note-0014){ref-type="fn"}   0.92                                      0.75 to 1.11                            0.38       0.86    0.74 to 1.01     0.07
  FHS 10‐yr risk of CVD                             0.87                                      0.74 to 1.02                            0.09       0.87    0.78 to 0.98     0.02
  10‐yr risk of ASCVD                               0.90                                      0.71 to 1.13                            0.35       0.82    0.69 to 0.98     0.02

AHA indicates American Heart Association; ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; FHS, Framingham Heart Study; LTPA, leisure time physical activity; SBP, systolic blood pressure.

LTPA‐related energy expenditure (LTPA‐EE) ≥1000 kcal/wk vs \<1000 kcal/wk.

Estimates and 95% CIs were from regular logistic regression or ordered logistic regression or generalized linear regression models adjusting for age, race, study centers, BMI, smoking status, and alcohol consumption.

ORs are reported to discrete outcomes, and mean differences (βs) were reported for continuous outcomes. For CVD risk scores, ORs comparing the high‐risk category vs the low‐risk category were obtained from ordered logistic regression models.

Diabetes was defined using self‐reported information and laboratory measurements (fasting plasma glucose level ≥7.0 mmol/L, 2‐hour postload plasma glucose ≥11.1 mmol/L, or HbA1c ≥6.5%).

###### 

Robustness of the Sex‐Specific Associations Between LTPA Status[a](#jah31557-note-0015){ref-type="fn"} and Cardio‐Metabolic Measures With the Effects of Study Centers Treated as Random Effects[b](#jah31557-note-0016){ref-type="fn"}

  Cardio‐Metabolic Variables                        Women (N=1183 Active and 4569 Inactive)   Men (N=1387 Active and 3446 Inactive)                                       
  ------------------------------------------------- ----------------------------------------- --------------------------------------- ---------- ------- ---------------- ----------
  SBP, mm Hg                                        −1.35                                     −2.31 to −0.39                          0.006      −1.09   −2.06 to −0.12   0.03
  DBP, mm Hg                                        −0.79                                     −1.41 to −0.18                          0.01       −1.71   −2.35 to −1.07   \<0.0001
  Heart rate, bpm                                   −1.96                                     −2.58 to −1.33                          \<0.0001   −4.30   −4.96 to −3.64   \<0.0001
  FHS CVD score                                     −0.38                                     −0.67 to −0.09                          0.01       −0.84   −1.17 to −0.51   \<0.0001
  ASCVD score                                       −0.17                                     −0.39 to 0.05                           0.12       −0.26   −0.62 to 0.08    0.14
  Hypertension                                      0.78                                      0.66 to 0.92                            0.003      0.76    0.65 to 0.88     0.0002
  Diabetes[d](#jah31557-note-0018){ref-type="fn"}   0.83                                      0.67 to 1.03                            0.09       0.73    0.61 to 0.87     0.0006
  FHS 10‐yr risk of CVD                             0.77                                      0.65 to 0.92                            0.004      0.67    0.57 to 0.78     \<0.0001
  10‐yr risk of ASCVD                               0.78                                      0.61 to 1.01                            0.06       0.71    0.59 to 0.85     0.0003

AHA indicates American Heart Association; ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; FHS, Framingham Heart Study; LTPA, leisure time physical activity; SBP, systolic blood pressure.

AHA guidelines recommend at least 150 min/wk moderate exercise or 75 min/wk vigorous exercise.

Estimates and 95% CIs were from generalized linear mixed models or cumulative link mixed models or linear mixed models with the effects of study centers treated as random effects, adjusting for age, race, BMI, smoking status, and alcohol consumption.

Odds ratios are reported to discrete outcomes, and mean differences (βs) were reported for continuous outcomes. For CVD risk scores, ORs comparing the high‐risk category vs the low‐risk category were obtained from cumulative link mixed models.

Diabetes was defined using self‐reported information and laboratory measurements (fasting plasma glucose level ≥7.0 mmol/L, 2‐hour postload plasma glucose ≥11.1 mmol/L, or HbA1c ≥6.5%).

Mediation Analysis {#jah31557-sec-0014}
------------------

We estimated that ≈32% (95% CI: 25--43), 32% (95% CI: 24--46), 33% (95% CI: 26--48), and 32% (95% CI: 25--51) of the total physical activity effects on hypertension, diabetes, the Framingham predicted 10‐year risk of CVD, and the ACC/AHA 2013 Guideline predicted 10‐year risk of ASCVD appeared to be mediated by BMI, respectively (Table [7](#jah31557-tbl-0007){ref-type="table-wrap"}). Systolic blood pressure levels mediated ≈28% (95% CI: 15--40) of the total effects of LTPA on hypertension risk, 7% (95% CI: 3--12) on diabetes risk, 26% (95% CI: 16--44) on the Framingham predicted 10‐year risk of CVD, and 23% (95% CI: 12--54) on the ACC/AHA 2013 Guideline predicted 10‐year risk of ASCVD. Diastolic blood pressure levels mediated 49% (95% CI: 31--66) of the total effects on hypertension, 10% (95% CI: 4--15) on diabetes risk, 40% (95% CI: 27--68) on the Framingham predicted 10‐year risk of CVD, and 31% (95% CI: 20--71) on the ACC/AHA 2013 Guideline predicted 10‐year risk of ASCVD. Sixteen percent (95% CI: 10--30) and 17% (95% CI: 10--43) of the total effects on the Framingham predicted 10‐year risk of CVD and the ACC/AHA 2013 Guideline predicted 10‐year risk of ASCVD were mediated by heart rate; 10% and 36% of the total effects on hypertension and diabetes were mediated by heart rate.

###### 

Proportion of Mediated Effects of Physical Activity on Cardio‐Metabolic Disease Risk

  Mediator              Proportion Mediated                  
  --------------------- --------------------- -------------- --------
  BMI                                                        
  Hypertension          0.32                  0.25 to 0.43   \<0.05
  Diabetes              0.32                  0.24 to 0.46   \<0.05
  10‐yr risk of CVD     0.33                  0.26 to 0.48   \<0.05
  10‐yr risk of ASCVD   0.32                  0.25 to 0.51   \<0.05
  SBP                                                        
  Hypertension          0.28                  0.15 to 0.40   \<0.05
  Diabetes              0.07                  0.03 to 0.12   \<0.05
  10‐yr risk of CVD     0.26                  0.16 to 0.44   \<0.05
  10‐yr risk of ASCVD   0.23                  0.12 to 0.54   \<0.05
  DBP                                                        
  Hypertension          0.49                  0.31 to 0.66   \<0.05
  Diabetes              0.10                  0.04 to 0.15   \<0.05
  10‐yr risk of CVD     0.40                  0.27 to 0.68   \<0.05
  10‐yr risk of ASCVD   0.31                  0.20 to 0.71   \<0.05
  Heart rate                                                 
  Hypertension          0.10                  0.04 to 0.15   \<0.05
  Diabetes              0.36                  0.21 to 0.57   \<0.05
  10‐yr risk of CVD     0.16                  0.10 to 0.30   \<0.05
  10‐yr risk of ASCVD   0.17                  0.10 to 0.43   \<0.05

ASCVD indicates arteriosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.

The mediator model adjusted for age, race, study centers, BMI, smoking status, and alcohol consumption. The explanatory variables of the outcome models include physical activity status, the mediator, and the same set of covariates adjusted in the mediator model.

95% CIs were obtained based on 50 quasi‐Bayesian simulations using robust standard errors.

Discussion {#jah31557-sec-0015}
==========

The current study presents the results based on detailed data carefully collected from more than 15 000 women and men who participated in the ELSA‐Brasil, which is the largest cohort of the Brazilian population to date. Ours is the first large‐scale multiethnic study to directly examine the role of LTPA in relation to cardio‐metabolic health in Brazilians. We observed significantly favorable profiles of cardio‐metabolic health among the physically active women and men, which provides direct evidence of demonstrable benefits of being active, characterized by a comprehensive set of CVD intermediate biomarkers and cardio‐metabolic diseases, for the Brazilian adult population. Physical activity was associated with improved profiles of blood pressure, heart rate, and the Framingham Risk Score for CVD in both women and men. Among women, physical activity was significantly associated with the reduced risk of hypertension and the reduced predicted 10‐year risk of CVD; among men, the risk of hypertension, diabetes, and the predicted 10‐year risk of CVD were significantly lower for the active, compared to the inactive.

According to the World Health Organization Non‐communicable Diseases Country Profiles 2011, the age‐standardized death rate per 100 000 due to CVD and diabetes alone were 304 for men and 226 for women in Brazil.[26](#jah31557-bib-0026){ref-type="ref"} The large proportion of physically inactive people in Brazil appears to play a significant role in the high morbidity and mortality for cardio‐metabolic diseases and highly prevalent cardio‐metabolic risk factors.[26](#jah31557-bib-0026){ref-type="ref"} In the current study, the prevalence of physical inactivity defined based on the AHA recommendation on leisure time physical activity is 75.72%, which corroborates the previous findings from the ELSA‐Brasil and Brazil\'s 2008 national surveillance system for risk and protective factors for chronic diseases (VIGITEL) survey.[11](#jah31557-bib-0011){ref-type="ref"}, [27](#jah31557-bib-0027){ref-type="ref"} The Brazilian government used results from the evaluations of LTPA intervention carried out by Project Guide for Useful Interventions for Physical Activity in Brazil and Latin America (GUIA), particularly the evaluation of the Academia da Cidade Program of the city of Recife (ACP),[28](#jah31557-bib-0028){ref-type="ref"}, [29](#jah31557-bib-0029){ref-type="ref"}, [30](#jah31557-bib-0030){ref-type="ref"}, [31](#jah31557-bib-0031){ref-type="ref"}, [32](#jah31557-bib-0032){ref-type="ref"}, [33](#jah31557-bib-0033){ref-type="ref"} to support statewide expansion of ACP by the government of the state of Pernambuco in 2010. In April 2011, the Brazilian Ministry of Health supported the expansion to over 4000 cities in Brazil of the Academia da Saúde (AS), a national program modeled after ACP. The AS is one of the few and possibly the largest physical activity and healthy lifestyle--promoting programs in the world.[28](#jah31557-bib-0028){ref-type="ref"} In 2005, Brazil published their first official dietary recommendation for the adult Brazilian population. Recently, a revised version based on food types rather than nutrients was launched.[34](#jah31557-bib-0034){ref-type="ref"} Brazil has adopted the World Health Organization Global Strategy on Diet, Physical Activity and Health, and much effort has been made to define healthy diet and physical activity policies and action. Although numerous initiatives have been taken by the Brazilian Ministry of Health,[35](#jah31557-bib-0035){ref-type="ref"}, [36](#jah31557-bib-0036){ref-type="ref"} there remains a need for more evidence about the effects of LTPA on cardio‐metabolic parameters directly from the adults in Brazil.

Results from the current study are also in line with those comprehensive findings from Brazil and the US population despite many significant differences in health systems, lifestyles, and socioeconomic factors between Brazil and the United States. A recent study using data from VIGITEL, Brazil\'s 2008 national surveillance system for risk and protective factors for chronic diseases, found that LTPA may be protective against hypertension in Brazilian men.[37](#jah31557-bib-0037){ref-type="ref"} However, no association was found between LTPA and hypertension for women in the same study. The authors suggested a possible explanation that women tended to report a lower level of LTPA and total amount of energy expenditure than men.[38](#jah31557-bib-0038){ref-type="ref"} In the current study, significant associations between LTPA and hypertension were found for both women and men after adjusting for a comprehensive set of covariates. The different findings for women from the current study may be due to the use of IPAQ‐based self‐reported physical activity levels. The validity of IPAQ in Brazilian populations has been evaluated previously.[39](#jah31557-bib-0039){ref-type="ref"} Results from the validation study indicated that IPAQ‐based measures can correctly classify individual levels of LTPA and are valid for the purpose of studying relations between LTPA and chronic diseases. According to the 2008 Physical Activity Guidelines Advisory Committee Report issued by the US Department of Health and Human Services, the median risk ratios of having coronary heart disease and CVD among men summarized from studies published since 1996 were 0.65 and 0.65, respectively; the median risk ratios for women were 0.62 and 0.89.[40](#jah31557-bib-0040){ref-type="ref"} The most inclusive meta‐analysis to date for the US population suggests that mean reductions in resting BP ranged from 2 to 5 mm Hg for SBP and 2 to 3 mm Hg for DBP across all categories.[41](#jah31557-bib-0041){ref-type="ref"} In the United States, large prospective cohort and cross‐sectional observational studies that assessed physical activity all show that increased levels of physical activity, both vigorous and moderate, are associated with a reduced risk for developing type 2 diabetes regardless of how these studies were conducted.[42](#jah31557-bib-0042){ref-type="ref"}, [43](#jah31557-bib-0043){ref-type="ref"}, [44](#jah31557-bib-0044){ref-type="ref"} The current findings for intermediate cardio‐metabolic biomarkers are also consistent with those from randomized controlled trials conducted in the United States. In a meta‐analysis of randomized controlled trials of 4 weeks or longer, the investigators found that aerobic exercise reduced SB by 4.7 mm Hg (95% CI: 4.4--5.0) and diastolic BP by 3.1 mm Hg (95% CI: 3.0--3.3) as compared to a nonexercising control group.[45](#jah31557-bib-0045){ref-type="ref"} A more recent meta‐analysis of randomized controlled trials showed consistent findings: a reduction of 6 (95% CI: 3--8) mm Hg in SBP and 5 (95% CI: 3--7) mm Hg in DBP was observed among hypertensive subjects; among normotensive subjects, the reduction was 2 (95% CI: 1--3) mm Hg for SBP and 1 (95% CI: 1--2) mm Hg for DBP.[46](#jah31557-bib-0046){ref-type="ref"} In addition, a most inclusive meta‐analysis of 160 randomized controlled trials suggested that physical activity significantly improved cardiorespiratory fitness and CVD biomarkers of lipid and lipoprotein metabolism, glucose intolerance and insulin resistance, systemic inflammation, and hemostasis, which may mediate the effects of physical activity on the risk of cardio‐metabolic diseases.[47](#jah31557-bib-0047){ref-type="ref"}

There are several aspects of our study that merit further discussion. One limitation of the current study is the cross‐sectional design, which cannot establish temporality for potential causal relation. Although the exploratory mediation analysis may provide some insight into the potential causal pathways, the results are preliminary due to the lack of clear temporality and need to be confirmed by further investigations. We are in the process of completing the second wave of data collection for physical activity and cardio‐metabolic outcomes in the ELSA‐Brasil. These prospective data linking physical activity and incident cardio‐metabolic diseases will be utilized to improve the longitudinal understanding of the physical activity--CVD relation. Secondly, the ELSA‐Brasil specifically targeted Brazilian adults, who have been understudied with respect to the effects of physical activity on cardio‐metabolic health. The study population comprises those who are employed and have high levels of education, which may limit its generalizability to the entire Brazilian population. Another potential limitation is the measurement error related to self‐reported physical activity levels. In the current study, the relations between self‐reported physical activity levels and cardio‐metabolic outcomes were evaluated using IPAQ‐based measures, which have been validated previously.[39](#jah31557-bib-0039){ref-type="ref"} Results from the validation study indicated that IPAQ‐based measures can correctly classify individual levels of LTPA and are valid for the purpose of studying relations between LTPA and chronic diseases. Although the physical activity measures are self‐reported, the cardio‐metabolic outcomes are objectively measured in the current study. Therefore, any measurement error in the exposure and outcome measures was less likely to be differential and dependent, which would have only led to a somewhat conservative estimate. In addition, the AHA and the World Health Organization recommendations are made for aerobic activity, while the IPAQ does not distinguish between resistance exercise and aerobic activity. However, the results from a sensitivity analysis show that our findings were robust to the use of an alternative definition of LTPA status.

Findings from our study have implications for future clinical and public health research and development of physical activity policies in Brazil. This cross‐sectional study is among the very first efforts to comprehensively and systematically investigate the role of physical activity in relation to cardio‐metabolic health in Brazil. The large sample size and wide variety of well‐characterized variables, including directly measured CVD biomarkers, make the ELSA‐Brasil a unique resource for investigators to study the determinants of cardio‐metabolic diseases in an understudied population. Our analyses corroborate that being physically active is significantly correlated with favorable profiles of cardio‐metabolic health in this large cohort, which is consistent with the findings from countries in North America and Europe. Findings from the current study suggest that it is possible to use lifestyle interventions to curb the epidemic of physical inactivity and cardio‐metabolic diseases in Brazil. Although the effect sizes observed for intermediate biomarkers were small to modest, the reduction of cardio‐metabolic risk, in terms of hypertension, diabetes, and CVD, was substantial and of clinical significance. By presenting the results for both the intermediate biomarkers and cardio‐metabolic diseases, our study helps to provide a comprehensive and coherent understanding of the relation between physical activity and cardio‐metabolic health. In addition, a mediation analysis was conducted to explore the potential mechanistic pathways leading from physical activity to the intermediate biomarkers and then to cardio‐metabolic diseases. Specifically, we measured the extent to which each intermediate biomarker may contribute to the overall effects of LTPA on each cardio‐metabolic disease of interest. Although the exact mediating mechanisms remain to be elucidated by future research using longitudinal data, preliminary findings from our exploratory mediation analysis suggest that substantial proportions of the effects of LTPA on cardio‐metabolic diseases may be mediated through the intermediate biomarkers. Together with the preceding analyses, the mediation analysis provides some innovative insights into the role of lifestyle interventions in the prevention of cardio‐metabolic diseases. More investigations, specifically targeting the Brazilian population, are needed to further clarify the mechanistic pathways, evaluate the effectiveness of currently ongoing interventions, inform the design of better‐targeted interventions in the future, and outline the practical guidelines for physicians to use in the management of physical inactivity and related cardio‐metabolic outcomes in the specific setting. Therefore, the current study results should support Brazil\'s ongoing efforts and that of other countries to develop interventions to increase levels of physical activity and improve cardio‐metabolic health outcomes in their populations.

In summary, our findings from a cross‐sectional study of 10 585 Brazilian adults point to the importance of physical activity in various aspects of cardio‐metabolic health among the Brazilian population. With the growing epidemics of cardio‐metabolic diseases and physical inactivity, especially in middle‐income countries like Brazil, an optimal prevention strategy should emphasize the promotion of a healthy lifestyle, which should include a key component of enhanced LTPA levels. Further investigation will establish a prospective relation between physical activity and cardio‐metabolic outcomes to inform public health policy and personalized interventions.
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